Health Care Down Sharply on Drug-Demand Fears -- Health Care Roundup

Published: 2025-05-09 17:35:07 ET MCK

Published on 05/09/2025 at 17:35

Health-care companies fell sharply amid concerns about the outlook for the pharmaceutical business.

"The health-care sector has experienced significant volatility so far in 2025, as the Trump administration weighs tariffs for pharmaceuticals and cuts funding for federal health agencies," said portfolio managers at money manager Janus Henderson.

Drug wholesaler McKesson plans to spin off its medical-surgical unit into a new company.

The National Institutes of Health and the Food and Drug Administration are launching a study on the impact of maternal and infant diets on long-range health outcomes.

Write to Rob Curran at [email protected]

(END) Dow Jones Newswires

05-09-25 1734ET